SEC Form 4 · accession 0001334549-19-000008
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David J Mazzo
Officer — Chief Executive Officer · Director
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 12:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2019 | F | 4,478 | $4.64 | D | 110,706 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 16,650 shares of unvested restricted stock.